Roche Diagnostics Australia held an Independent Medical Education meeting exploring the approach to Hepatocellular Carcinoma (HCC) surveillance in Australia in Melbourne.

The event aimed to provide valuable insights into the latest advancements, challenges, and strategies surrounding HCC surveillance.

The meeting featured presentations from esteemed experts including A/Prof Simone Strasser, A/Prof Jessica Howell, Dr Manfred Spanger and Dr Ericka Flores and a panel discussion involving real-world case studies.

When asked on the key takeaways for the meeting A Prof Simone Strasser commented “…an understanding of the changing epidemiology of liver disease and liver cancer in Australia, and that we are going to have to enable the healthcare system and primary care to apply surveillance to
more and more people and that’s not going to be ultrasound based surveillance because we don’t have enough ultrasound practices and technicians in Australia to be able to apply to the whole community at risk and so we are going to need to have blood biomarkers that are applicable to that community.”

Roche Diagnostics Australia hosted an information evening dedicated to exploring the current diagnostic tools and management criteria of liver cancer, also known as hepatocellular carcinoma (HCC), in Australia.

Secondary care clinicians (specialists) such as gastroenterologists, hepatologists, and oncologists from across Australia were invited to a thought-provoking HCC surveillance educational event in Melbourne.

In this engaging session, three Australian liver cancer experts shed light on the current standard of care in Australia, HCC surveillance strategies, and blood-based biomarkers to assist in early diagnosis.

Watch the highlight video and full presentation video here.